Management of heavy menstrual bleeding in adolescents

Current Opinion in Obstetrics and Gynecology

Volumn 24, Issue 5, 2012, Pages 275-280

  Sokkary, Nancy ^a   Dietrich, Jennifer E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

adolescent; heavy menstrual bleeding; menorrhagia

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; DESMOPRESSIN; ESTROGEN; ETONOGESTREL; LEUPRORELIN; LEVONORGESTREL; MEDROXYPROGESTERONE; MEDROXYPROGESTERONE ACETATE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; TRANEXAMIC ACID; VON WILLEBRAND FACTOR;

ADOLESCENT DISEASE; BLEEDING DISORDER; BLOOD CLOTTING FACTOR DEFICIENCY; BLOOD DYSCRASIA; CLINICAL FEATURE; CURETTAGE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; HORMONAL CONTRACEPTION; HUMAN; HYPONATREMIA; INTRAUTERINE CONTRACEPTIVE DEVICE; MENORRHAGIA; OSTEOPENIA; PATIENT COMPLIANCE; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE DYSFUNCTION; THROMBOCYTOPENIA; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MENORRHAGIA; PRACTICE GUIDELINES AS TOPIC;

EID: 84866425761     PISSN: 1040872X     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/GCO.0b013e3283562bcb     Document Type: Review

References (25)

1. Benjamins L. Practice Guideline: Evaluation and management of abnormal vaginal bleeding in adolescents. J Ped Healthcare 2009; 23:189-193.
2. Jayasinghe Y, Moore P, Donath S, et al. Bleeding disorders in teenagers presenting with menorrhagia. Aust N Z J Obstet Gynecol 2005; 45:439-443. (Pubitemid 41830370)
3. Chi C, Pollard D, Tuddenham EG, Kadir RA. Menorrhagia in adolescents with inherited bleeding disorders. J Pediatr Adolesc Gynecol 2010; 23:215-222.
4. Frishman GN. Evaluation and treatment of menorrhagia in an adolescent population. J Minimally Invasive Gynecol 2008; 15:682-688.
5. Pawar A, Krishnana R, Davis K, et al. Perceptions about quality of life in a school-based population of adolescents with menorrhagia: implications for adolescents with bleeding disorders. Haemophilia 2008; 14:579-583. (Pubitemid 351638747)
6. Morbidity and Mortality weekly report. CDC Youth Risk Behavior Survey 2009. 2010; 59: 20.
7. Centers of Disease Control STD Surveillance 2010. Atlanta Department of Health and Human Services; 2011.
8. James Ah. Bleeding disorders in adolescents. Obstet Gynecol Clinics N Amer 2009; 36:153-162.
9. Philip CS, Faiz A, Dowling N, et al. Age and prevalence of bleeding disorders in women with menorrhagia. Obstet Gynecol 2005; 105:61-66. (Pubitemid 40189912)
10. Kakuno Y, Amino N, Kanoh M, et al. Menstrual disturbances in various thyroid disease. Endo J 2010; 57:1017-1022.
11. Ahuja S, Hertweck P. Overview of bleeding disorders in adolescent females with menorrhagia. J Pediatr Adolesc Gynecol 2010; 23:S15.
12. Kulp J, Mwangi C, Loveless M. Screening for coagulation disorders in adolescents with abnormal uterine bleeding. J Pediatr Adolesc Gynecol 2008; 21:27-30. (Pubitemid 351179989)
13. Mikhail S, Kouides P. von Willebrand disease in the pediatric and adolescent population. J Pediatr Adolesc Gynecol 2010; 23:S3-S10.
14. Sidonio R, Smith K, Ragni M. Cost-utility analysis of von Willebrand disease screening in adolescents with menorrhagia. J Pediatr 2010; 157:456-460.
15. Philipp CS. Platelet disorders in adolescents. J Pediatr Adolesc Gynecol 2010; 23:S11-S14.
16. Mezzano D, Quiroga T, Pereira J. The level of laboratory testing required for diagnosis or exclusion of a platelet function disorder using platelet aggregation and secretion assays. Semin Thromb Hemost 2009; 35:24.
17. Hayward CP, Moffat KA, Raby A, et al. Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry. Am J Clin Pathol 2010; 134:955-963.
18. Naik S, Teruya J, Dietrich J, et al. Utility of platelet function analyzer as a screening tool for the diagnosis of Von Willebrand diease in adolescents with menorrhagia. In: XXIIIrd Congress of the International Society of Thrombosis and Haemostasis (ISTH). Kyoto, Japan 2011.P-TH-485, 388.
19. Wilkinson J, Kadir R. Management of abnormal uterine bleeding in adolescents. J Pediatr Adolesc Gynecol 2010; 23:S22-S30.
20. Devore G, Owens O, Kase N. Use of intravenous premarin in the treatment of dysfunctional uterine bleeding-A double-blinded randomized control study. Obstet Gynecol 1982; 52:285.
21. Kaunitz A, Darney P, Ross D, et al. Subcutaneous DMPA vs intramuscular DMPA: a 2 year randomized study of contraceptive efficacy and bone mineral density 2009; 80:1-13.
22. James A, Kouides P, Abdul-Kadir R, et al. Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: consensus from international expert panel. Eur J Obstet Gynecol Reprod Biol 2011; 158:124-134.
23. Peterson H, Ashton J, Harrison-Woolrych M. A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents. Contraception 2009; 79:433-438.
24. KingmanC, Kadir R, Lee C, Economides D. The uses of levonorgestrel- releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders. Internat J Obstet Gynecol 2004; 111:1425-1428. (Pubitemid 39665035)
25. Lethaby A, Augood C, Duckitt K, Farquhar C. Non steroidal anti-inflammatory drugs for heavy menstrual bleeding. A Cochrane review. The Cochrane Library 2010; 11:1-41.